A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness - PubMed (original) (raw)
. 1998 Oct;178(4):1163-6.
doi: 10.1086/515675.
Affiliations
- PMID: 9806051
- DOI: 10.1086/515675
A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness
D A Wilkinson et al. J Infect Dis. 1998 Oct.
Abstract
The beta-chemokine receptor CCR5 is required as a coreceptor by non-syncytium-inducing (NSI) strains of human immunodeficiency virus type 1 (HIV-1). NSI viruses predominate early during an infection and are thought to be important for the transmission of HIV-1. The importance of CCR5 during parenteral transmission of HIV-1 was investigated. The distribution of the homozygous deleted CCR5 genotype among 566 exposed persons with hemophilia and 97 exposed transfusion recipients indicated that the lack of CCR5 expression protected persons from infection. This suggests that the initial predominance of NSI viruses during an infection does not result from limited availability of CXCR4-expressing cells within the mucosa but rather implies a more fundamental requisite for CCR5-expressing cells early during an infection regardless of the route of transmission. In addition, no difference in the rate of progression to AIDS (CDC 1987 definition) of infected heterozygous compared with homozygous wild type subjects was observed.
Comment in
- CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection.
Williams SB, Flanigan TP, Artenstein AW, VanCott TC, Smith D, Mayer K, Koup RA. Williams SB, et al. J Infect Dis. 1999 May;179(5):1310-2. doi: 10.1086/314743. J Infect Dis. 1999. PMID: 10191415 No abstract available.
Similar articles
- Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.
van Rij RP, Portegies P, Hallaby T, Lange JM, Visser J, de Roda Husman AM, van 't Wout AB, Schuitemaker H. van Rij RP, et al. J Infect Dis. 1999 Sep;180(3):854-7. doi: 10.1086/314940. J Infect Dis. 1999. PMID: 10438379 - The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
Paxton WA, Kang S, Koup RA. Paxton WA, et al. AIDS Res Hum Retroviruses. 1998 Apr;14 Suppl 1:S89-92. AIDS Res Hum Retroviruses. 1998. PMID: 9581891 - Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.
Buseyne F, Janvier G, Teglas JP, Ivanoff S, Burgard M, Bui E, Mayaux MJ, Blanche S, Rouzioux C, Rivière Y. Buseyne F, et al. J Infect Dis. 1998 Oct;178(4):1019-23. doi: 10.1086/515660. J Infect Dis. 1998. PMID: 9806029 - HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
Smoleń-Dzirba J, Rosińska M, Janiec J, Beniowski M, Cycoń M, Bratosiewicz-Wąsik J, Wąsik TJ. Smoleń-Dzirba J, et al. AIDS Rev. 2017 Dec;19(4):219-230. AIDS Rev. 2017. PMID: 28534889 Review. - HIV cure: Are we going to make history?
Payra S, Manjhi PK, Singh S, Kumar R, Singh SK, Kumar A, Maharshi V. Payra S, et al. HIV Med. 2024 Mar;25(3):322-331. doi: 10.1111/hiv.13557. Epub 2023 Oct 11. HIV Med. 2024. PMID: 37821095 Review.
Cited by
- Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review.
Kandula UR, Wake AD. Kandula UR, et al. Biologics. 2022 Jul 8;16:89-105. doi: 10.2147/BTT.S368152. eCollection 2022. Biologics. 2022. PMID: 35836496 Free PMC article. Review. - Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression.
Martinez-Navio JM, Fuchs SP, Pantry SN, Lauer WA, Duggan NN, Keele BF, Rakasz EG, Gao G, Lifson JD, Desrosiers RC. Martinez-Navio JM, et al. Immunity. 2019 Mar 19;50(3):567-575.e5. doi: 10.1016/j.immuni.2019.02.005. Epub 2019 Mar 5. Immunity. 2019. PMID: 30850342 Free PMC article. - Therapy of HIV Infection: Current Approaches and Prospects.
Prokofjeva MM, Kochetkov SN, Prassolov VS. Prokofjeva MM, et al. Acta Naturae. 2016 Oct-Dec;8(4):23-32. Acta Naturae. 2016. PMID: 28050264 Free PMC article. - Why cure, why now?
Kuritzkes DR. Kuritzkes DR. J Med Ethics. 2017 Feb;43(2):67-70. doi: 10.1136/medethics-2015-103113. Epub 2016 Jun 7. J Med Ethics. 2017. PMID: 27273887 Free PMC article. - Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches.
Santa-Marta M, de Brito PM, Godinho-Santos A, Goncalves J. Santa-Marta M, et al. Front Immunol. 2013 Oct 24;4:343. doi: 10.3389/fimmu.2013.00343. Front Immunol. 2013. PMID: 24167505 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical